Antifungal action of the oxathiolone-fused chalcone derivative

Mycoses

Volumn 54, Issue 5, 2011, Pages

  Łacka, Izabela ^a   Konieczny, Marek T ^b   Bulłakowska, Anita ^b   Rzymowski, Tomasz ^a   Milewski, Slławomir ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Antifungal agents; Candida spp.; Cell wall

Indexed keywords

1,3 BETA GLUCAN SYNTHASE; AMG 148; ANTIFUNGAL AGENT; CDR1 PROTEIN; CDR2 PROTEIN; CHALCONE DERIVATIVE; CHITIN; FLUCONAZOLE; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA ARBOREA; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA QUILLIERMONDII; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; CONTROLLED STUDY; DRUG MECHANISM; FUNGAL STRAIN; GALACTOMYCES GEOTRICHUM; IN VITRO STUDY; KLUYVEROMYCES MARXIANUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RHODOTORULA MUCILAGINOSA; SACCHAROMYCES CEREVISIAE; YARROWIA LIPOLYTICA;

BETA-GLUCANS; CANDIDA ALBICANS; CHALCONE; CHITIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; SULFHYDRYL COMPOUNDS;

CANDIDA; CANDIDA ALBICANS;

EID: 80052785444     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01936.x     Document Type: Article

References (30)

1. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-63.
2. Monk BC, Goffeau A. Outwitting multidrug resistance to antifungals. Science 2008; 321: 367-9.
3. Sanglard D, Odds F. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2: 73-85.
4. Odds FC, Brown AJ, Gow NA. Antifungal agents: mechanisms of action. Trends Microbiol 2003; 11: 272-9.
5. Georgopapadakou NH, Tkacz JS. The fungal cell wall as a drug target. Trends Microbiol 1995; 3: 98-104.
6. Liu J, Balasubramanian MK. 1, 3-β-glucan synthase: a useful target for antifungal drugs. Curr Drug Targets Infect Disord 2001; 1: 159-69.
7. Dimmock JR, Elias DW, Beazely MA et al. Bioactivities of chalcones. Curr Med Chem 1999; 6: 1125-49.
8. Lopez SN, Castelli MV, Zacchino SA et al. In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorg Med Chem 2001; 9: 1999-2013.
9. Boeck P, Leal PC, Yunes RA et al. Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones. Arch Pharm Chem Life Sci 2005; 338: 87-95.
10. Sivakumar PM, Muthu Kumar T, Doble M. Antifungal activity, mechanism and QSAR studies on chalcones. Chem Biol Drug Des 2009; 74: 68-79.
11. Konieczny MT, Konieczny M, Sabisz M et al. Synthesis of isomeric, oxathiolone fused chalcones and comparison of their activity toward various microorganisms and human cancer cells line. Chem Pharm Bull 2007; 55: 817-20.
12. Konieczny MT, Konieczny W, Pirska D et al. Synthesis of oxathiolone fused chalcones bearing O-aminoalkyl side chain. Comparison of stability of isomeric benzoxathiolones under alkylation reaction conditions. Heterocycles 2007; 71: 2595-615.
13. Konieczny MT, Konieczny W, Sabisz M et al. Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line. Eur J Med Chem 2007; 42: 729-33.
14. Franz R, Ruhnke M, Morschhaüser J. Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 1999; 42: 453-8.
15. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts - second edition. Approved standard M27-A2. Wayne, PA: NCCLS, 2002.
16. Varga I, Sóczó G, Kardos G, Majoros L. Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3. J Antimicrob Chemother 2008; 62: 149-52.
17. Lee KL, Buckley HR, Campbell CC. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 1975; 3: 148-53.
18. Ślisz M, Cybulska B, Grzybowska J et al. The mechanism of overcoming multidrug resistance (MDR) of fungi by amphotericin B and its derivatives. J Antibiot 2007; 60: 436-46.
19. Kippert F, Lloyd D. The aniline blue fluorochrome specifically stains the septum of both live and fixed Schizosaccharomyces pombe cells. FEMS Microbiol Lett 1995; 132: 215-9.
20. Bulawa CE, Slater M, Cabib E et al. The S. cerevisiae structural gene for chitin synthase is not required for chitin synthesis in vivo. Cell 1986; 46: 213-25.
21. Wu XZ, Cheng AX, Sun LM et al. Effect of plagiochin E, an antifungal macrocyclic bis(dibenzyl), on cell wall chitin synthesis in Candida albicans. Acta Pharmacol Sin 2008; 29: 1478-85.
22. Shedletzky E, Unger C, Delmer DP. A microtiter-based fluorescence assay for (1, 3)-β-glucan synthases. Anal Biochem 1997; 249: 88-93.
23. Katz M, Johanson T, Gorwa-Grauslund MF. Mild detergent treatment of Candida tropicalis reveals a NADPH-dependent reductase in the crude membrane fraction, which enables the production of pure bicyclic exo-alcohol. Yeast 2004; 21: 1253-67.
24. Whiteway M, Oberholzer U. Candida morphogenesis and host-pathogen interactions. Curr Opin Microbiol 2004; 7: 350-7.
25. Chattaway FW, Holmes MR, Barlow AJE. Cell wall composition of the mycelial and blastospore forms of Candida albicans. J Gen Microbiol 1968; 51: 367-76.
26. Gozalbo D, Roig P, Villamón E et al. Candida and candidiasis: the cell wall as a potential target for antifungal therapy. Curr Drug Targets Infect Disord 2004; 4: 117-35.
27. Elorza MV, Murgui A, Rico H et al. Formation of a new cell wall by protoplasts of Candida albicans: effect of papulacandin B, tunicamycin and nikkomycin. J Gen Microbiol 1987; 133: 2315-25.
28. Latgè JP. The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol 2007; 66: 279-90.
29. Ruiz-Herrera J, San-Blas G. Chitin synthesis as target for antifungal drugs. Curr Drug Targets Infect Disord 2003; 3: 77-91.
30. Bang KH, Lee DW, Park HM et al. Inhibition of fungal cell wall synthesizing enzymes by trans-cinnamaldehyde. Biosci Biotechnol Biochem 2000; 64: 1061-3.